Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Dapagliflozin for Heart Failure
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will test if an investigational drug can prevent heart failure from getting worse in adults with Fontan circulation. It will involve visits and phone calls to measure health, exercise, body water, & blood pressure.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service